Mettler-Toledo International, Inc. (NYSE:MTD) Receives Consensus Recommendation of “Hold” from Brokerages

Mettler-Toledo International, Inc. (NYSE:MTD) has earned a consensus recommendation of “Hold” from the thirteen research firms that are presently covering the stock, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $1,435.4167.

A number of research analysts have commented on the company. Barclays reduced their price objective on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research note on Monday, December 15th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Mettler-Toledo International in a report on Monday, December 29th. Morgan Stanley decreased their price target on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating for the company in a report on Tuesday, February 10th. Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective for the company in a research report on Monday, December 15th. Finally, Stifel Nicolaus boosted their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Monday, November 10th.

Insider Buying and Selling

In related news, insider La Guerroniere Marc De sold 6,055 shares of the stock in a transaction dated Tuesday, November 25th. The stock was sold at an average price of $1,488.18, for a total value of $9,010,929.90. Following the completion of the transaction, the insider owned 187 shares of the company’s stock, valued at approximately $278,289.66. This represents a 97.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Shawn Vadala sold 800 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total value of $1,128,096.00. Following the sale, the chief financial officer owned 5,288 shares in the company, valued at $7,456,714.56. This represents a 13.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 9,116 shares of company stock valued at $13,473,111 in the last quarter. Company insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Hedge funds have recently made changes to their positions in the stock. Strive Financial Group LLC acquired a new stake in shares of Mettler-Toledo International during the fourth quarter worth approximately $1,962,000. Mercer Global Advisors Inc. ADV boosted its stake in Mettler-Toledo International by 43.5% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 812 shares of the medical instruments supplier’s stock valued at $1,131,000 after acquiring an additional 246 shares during the last quarter. EP Wealth Advisors LLC acquired a new position in Mettler-Toledo International during the 4th quarter worth $265,000. Mackenzie Financial Corp grew its holdings in Mettler-Toledo International by 29.7% during the 4th quarter. Mackenzie Financial Corp now owns 3,192 shares of the medical instruments supplier’s stock worth $4,506,000 after acquiring an additional 730 shares in the last quarter. Finally, Empowered Funds LLC increased its position in shares of Mettler-Toledo International by 186.4% in the 4th quarter. Empowered Funds LLC now owns 1,661 shares of the medical instruments supplier’s stock worth $2,316,000 after purchasing an additional 1,081 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Stock Up 1.7%

MTD opened at $1,376.75 on Thursday. Mettler-Toledo International has a 52-week low of $946.69 and a 52-week high of $1,525.17. The company has a 50 day moving average of $1,414.70 and a two-hundred day moving average of $1,366.51. The company has a market cap of $27.99 billion, a P/E ratio of 32.69, a P/E/G ratio of 2.84 and a beta of 1.42.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, beating analysts’ consensus estimates of $12.76 by $0.60. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The business had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter last year, the firm posted $12.41 EPS. The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. Research analysts anticipate that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.